Year: 2020
Type: review
Abstract: Exosomes are small extracellular vesicles released by almost all cell types in physiological and pathological conditions. The exosomal potential to unravel disease mechanisms, or to be used as a source of biomarkers, is being explored, in particularly in the field of neurodegenerative diseases. Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the world and exosomes appear to have a relevant role in disease pathogenesis. This review summarizes the current knowledge on exosome contributions to AD as well as their use as disease biomarker resources or therapeutic targets. The most recent findings with respect to both protein and miRNA biomarker candidates for AD, herein described, highlight the state of the art in this field and encourage the use of exosomes derived from biofluids in clinical practice in the near future.
Source: Journal of Neurochemistry
DOI: 10.1111/jnc.15112
Institution: University of Aveiro
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,600
Awards: G1167214205, G121659266, G1295472041, G1516346500, G1578237752, G1763632427, G2082818883, G2127175253, Blood-derived exosomes for biomarker discovery in AD – BMKDisc-AD, Exosomal biomarkers for Alzheimers disease - ExoAD, G2792627247, G3087251695, G3840324753, G4438819054, G4919897300, G5224927334, G5454278309, Diagnóstico precoce e preditivo na doença de Alzheimer baseado em sangue, G6929588092, Instituto de Biomedicina - Aveiro
OpenAlex ID: W3039306930
